{
    "ticker": "CSL",
    "name": "CSL Limited",
    "description": "CSL Limited is a global biotechnology company that develops and delivers innovative medicines to treat serious and chronic medical conditions. Founded in 1916 in Australia, CSL has grown to become one of the largest biotechnology companies in the world, with a presence in over 60 countries. The company specializes in the development of therapies derived from human plasma, as well as recombinant proteins and gene therapies. CSL's major product lines include immunoglobulins for immune deficiencies, albumin for critical care, and clotting factor products for hemophilia. The company is also heavily involved in research and development, with a commitment to advancing science through the discovery of new therapies and treatment options. CSL's mission is to save lives and improve the quality of life for patients globally, and it has built a reputation for excellence in the biopharmaceutical sector. The company is committed to sustainability and ethical practices, focusing on patient needs while also ensuring compliance with regulatory standards. With a strong pipeline of products and a robust portfolio of ongoing clinical trials, CSL is well-positioned for future growth and innovation in the biopharmaceutical industry.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "Parkville, Victoria, Australia",
    "founded": "1916",
    "website": "https://www.csl.com.au",
    "ceo": "Paul Perreault",
    "social_media": {
        "twitter": "https://twitter.com/csllimited",
        "linkedin": "https://www.linkedin.com/company/csl-limited/"
    },
    "investor_relations": "https://investors.csl.com.au",
    "key_executives": [
        {
            "name": "Paul Perreault",
            "position": "CEO"
        },
        {
            "name": "Graham Hetzel",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Plasma-derived Therapies",
            "products": [
                "Immunoglobulins",
                "Albumin",
                "Clotting Factors"
            ]
        },
        {
            "category": "Recombinant Therapies",
            "products": [
                "Recombinant Factor VIIa",
                "Recombinant Protein Products"
            ]
        },
        {
            "category": "Gene Therapies",
            "products": [
                "Glybera",
                "Potential Future Products"
            ]
        }
    ],
    "seo": {
        "meta_title": "CSL Limited | Global Biotechnology Leader",
        "meta_description": "Explore CSL Limited, a leading biotechnology company dedicated to developing innovative medicines for serious and chronic conditions. Learn about CSL's products, mission, and commitment to patient care.",
        "keywords": [
            "CSL",
            "Biotechnology",
            "Pharmaceuticals",
            "Plasma-derived Therapies",
            "Gene Therapy",
            "Immunoglobulins",
            "Recombinant Proteins"
        ]
    },
    "faq": [
        {
            "question": "What does CSL Limited specialize in?",
            "answer": "CSL Limited specializes in biotechnology, focusing on developing innovative medicines from human plasma and recombinant proteins."
        },
        {
            "question": "Who is the CEO of CSL Limited?",
            "answer": "Paul Perreault is the CEO of CSL Limited."
        },
        {
            "question": "Where is CSL Limited headquartered?",
            "answer": "CSL Limited is headquartered in Parkville, Victoria, Australia."
        },
        {
            "question": "What are CSL's main products?",
            "answer": "CSL's main products include immunoglobulins, albumin, clotting factor products, and various recombinant therapies."
        },
        {
            "question": "When was CSL Limited founded?",
            "answer": "CSL Limited was founded in 1916."
        }
    ],
    "competitors": [
        "BAX",
        "GRFS",
        "SHPG"
    ],
    "related_stocks": [
        "NVS",
        "ABBV",
        "AMGN",
        "PFE"
    ]
}